Increasing Access to and Availability of Sustainable, High Quality, Comprehensive Health and Structural Interventions among Key Populations and Priority Populations in the Western and Rift Valley Regions of the Republic of Kenya under the President&# | CDC RFA GH16 1716

Opportunity Information: Apply for CDC RFA GH16 1716

The grant opportunity titled "Increasing Access to and Availability of Sustainable, High Quality, Comprehensive Health and Structural Interventions among Key Populations and Priority Populations in the Western and Rift Valley Regions of the Republic of Kenya under the President's Emergency Plan for AIDS Relief (PEPFAR)" is a CDC-funded cooperative agreement (Funding Opportunity Number: CDC RFA GH16-1716; CFDA: 93.067) focused on accelerating HIV epidemic control in Kenya, specifically in the Western and Rift Valley regions. The overall intent is to expand and strengthen comprehensive, evidence-based HIV prevention, care, and treatment services for key populations (KP) and priority populations (PP), while also addressing the broader structural barriers that make these services harder to access or sustain. The program is framed to align with PEPFAR 3.0 and the Kenya AIDS Strategic Framework (KASF), emphasizing measurable progress toward reducing new infections and HIV-related illness and death.

At the service delivery level, the opportunity prioritizes scaling up interventions that are known to work, not experimental approaches. The core outcomes highlighted are preventing new HIV infections, reducing HIV-related morbidity and mortality, and reducing risk behaviors, with an explicit commitment to protecting the rights and dignity of KP and PP. In practice, this implies a package of HIV prevention and treatment supports that typically includes targeted HIV testing services, rapid linkage to care, antiretroviral therapy initiation and retention support, viral load monitoring and suppression efforts, and integrated prevention options appropriate to different population needs. The language also makes clear that the program is not only about clinical services; it is equally about creating conditions in which KP and PP can safely and consistently access those services without discrimination, stigma, or other rights-related harms.

A major pillar of the announcement is health systems strengthening (HSS) at the county level. The FOA describes HSS as a way to build a more robust and responsive local health system that can maintain progress over time and contribute to sustainable epidemic control. In real-world terms, this kind of strengthening commonly involves improving county-level planning and coordination, strengthening data systems and strategic information use, enhancing supply chain and commodity management, building the capacity of health workers and implementing partners, and improving service quality assurance and accountability mechanisms. The emphasis on county systems reflects Kenya's devolved health governance and the need for durable local capacity rather than short-term, partner-dependent gains.

From an administrative standpoint, this opportunity is classified as a discretionary award using a cooperative agreement mechanism. A cooperative agreement typically means CDC would expect to have substantial involvement in the implementation through technical collaboration, performance monitoring, and ongoing coordination, rather than simply issuing funds and stepping back. The listing indicates an award ceiling of $14,000,000, with one expected award, suggesting the program was designed for a single lead implementer capable of operating at meaningful scale across the targeted regions.

The notice also includes an important update: the text provided describes an amendment that is strictly informational. CDC is not accepting new applications, and the amendment's purpose is to add language regarding HIV epidemic control under a section titled "Other National Public Health Priorities and Strategies." The original closing date listed for applications was 2016-02-04, and the opportunity was created on 2015-12-04, reinforcing that this is a past funding action that has since been updated in documentation rather than reopened for competition.

Eligibility, as described, is broad and includes many categories of domestic and non-domestic organizations. Eligible applicants span multiple levels of government (state, county, city/township, special districts, regional organizations), public and private institutions of higher education, nonprofits with or without 501(c)(3) status, for-profit entities (including small businesses), individuals, and various specialized institution types (for example, Hispanic-serving institutions, HBCUs, and Alaska Native/Native Hawaiian-serving institutions). The FOA also explicitly lists non-U.S. entities and a range of other organization types that could reasonably implement HIV programming, including Ministries of Health, tribal epidemiology centers, urban Indian health organizations, research institutions conducting non-research activities, colleges and universities, community-based organizations, faith-based organizations, hospitals, and small, minority-, and women-owned businesses. Taken together, this eligibility language signals an intent to allow a wide field of potential implementers, provided they can deliver large-scale, evidence-based HIV programming and systems strengthening aligned with national and PEPFAR strategies.

• The Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Increasing Access to and Availability of Sustainable, High Quality, Comprehensive Health and Structural Interventions among Key Populations and Priority Populations in the Western and Rift Valley Regions of the Republic of Kenya under the President&#" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on 2015-12-04.
• Applicants must submit their applications by 2016-02-04. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $14,000,000.00 in funding.
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Others.

Apply for CDC RFA GH16 1716

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: